首页> 外文期刊>International journal of applied mechanics >BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming
【24h】

BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming

机译:通过糖酵解代谢重编程促进HBX诱导的肝细胞癌细胞的HBX诱导的癌症茎秆

获取原文
获取原文并翻译 | 示例
       

摘要

Hepatitis B virus (HBV) is one of predisposing factors for hepatocellular carcinoma (HCC). The role of HBV x protein (HBx) in mediating the induction and maintenance of cancer stemness during HBV-related HCC attracts considerable attention, but the exact mechanism has not been clearly elucidated. Here, ABCG2-dependent stem-like side population (SP) cells, which are thought to be liver cancer stem cells (LCSCs), were present in HCC cells, and the fraction of this subset was increased in HBx-expressing HCC cells. In addition, glycolysis was upregulated in LCSCs and HBx-expressing HCC cells, and intervention of glycolysis attenuated cancer stem-like phenotypes. Mitochondria play an important role in the maintenance of energy homeostasis, BNIP3L-dependent mitophagy was also activated in LCSCs and HBx-expressing HCC cells, which triggered a metabolic shift toward glycolysis. In summary, we proposed a positive feedback loop, in which HBx induced BNIP3L-dependent mitophagy which upregulated glycolytic metabolism, increasing cancer stemness of HCC cells in vivo and in vitro. BNIP3L might be a potential therapeutic target for intervention of LCSCs-associated HCC. Anti-HBx, a monoclonal antibody targeting intracellular HBx, had the potential to delay the progression of HBV infection related-HCC.
机译:乙型肝炎病毒(HBV)是肝细胞癌(HCC)的易用因素之一。 HBV X蛋白(HBX)在HBV相关的HCC期间介导癌症源的诱导和维持的作用吸引了相当大的关注,但没有明确阐明确切的机制。这里,认为是肝癌干细胞(LCSCs)的ABCG2依赖性干细胞(SP)细胞存在于HCC细胞中,并且在表达HBX的HCC细胞中增加该子集的级分。此外,在LCSCs和HBX表达HCC细胞中上调糖酵解,并且糖酵解的干预减弱了癌症干燥的表型。线粒体在维持能量稳态中发挥重要作用,在LCSCs和HBX表达HCC细胞中也被激活了BNIP3L依赖性的影响,这引发了糖酵解的代谢转变。总之,我们提出了一种阳性反馈回路,其中HBX诱导了BNIP3L依赖性的影响,其上调了糖酵解代谢,增加了体内HCC细胞的癌症茎,并且体外。 BNIP3L可能是潜在的治疗目标,用于干预LCSCs相关的HCC。抗HBX,靶向细胞内HBX的单克隆抗体,具有促进HBV感染相关HCC的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号